VIA
MBX

Virtus Investment Advisers’s MBX Biosciences MBX Stock Holding History

Virtus Investment Advisers’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Buy
9,215
+84
+0.9% +$2.93K 0.12% 208
2026
Q1 		$273K Buy
9,131
+221
+2% +$7.52K 0.08% 297
2025
Q4 		$281K Sell
8,910
-1,704
-16% -$41.3K 0.08% 269
2025
Q3 		$186K Buy
10,614
+1,842
+21% +$24.6K 0.05% 263
2025
Q2 		$100K Buy
8,772
+766
+10% +$7.8K 0.03% 331
2025
Q1 		$59.1K Buy
+8,006
New +$84.6K 0.02% 462

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Virtus Investment Advisers's MBX Position: Q2 2026 in Review

Virtus Investment Advisers increased its MBX Biosciences (MBX) stake by 0.92% in Q2 2026, buying an estimated $2.93K and bringing the position to 9,215 shares worth $509K. The position accounts for 0.12% of the portfolio, ranked #208.

Virtus Investment Advisers first reported a position in MBX in Q1 2025 and has held it in 6 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Virtus Investment Advisers held 9,215 shares of MBX Biosciences worth $509K as of Q2 2026.
  • Virtus Investment Advisers bought 84 MBX Biosciences shares in Q2 2026, an estimated $2.93K.
  • MBX Biosciences made up 0.12% of Virtus Investment Advisers's portfolio in Q2 2026, its #208 holding.
  • Virtus Investment Advisers first reported a position in MBX Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.